CClinicalTrials.gg
CompletedNCT01113827Updated Mar 27, 2012

Effects of Water-soluble Olive Extract Supplementation

An interventional study of Olive Extract and Placebo in Healthy, sponsored by University of Texas at Austin. Completed at 1 site in United States. Open to male participants aged 20 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2012-03-27.

Sponsored by University of Texas at Austin · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
61
Allocation
Randomized
Ages
20 Years to 35 Years
Sex
Male
01

Study summary

Six weeks of supplementation of an olive extract will:

  • Improve antioxidant status
  • Reduce inflammation
  • Reduce muscle damage
  • Improve exercise performance
  • Improve exercise recovery as compared to a placebo.
02

Conditions studied

  • Healthy

Keywords

  • Olive
  • antioxidant
  • exercise
  • inflammation
  • recovery
  • Healthy men
03

In context

Lead sponsor

University of Texas at Austin is the lead sponsor of 319 studies on the registry; 78 are open to participants now.

Of its 10 completed or terminated interventional studies of FDA-regulated products, 5 (50%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 35 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Inclusion criteria

  • Recreational exerciser
  • BMI \<= 30
  • Non-smoker

Exclusion criteria

Exclusion Criteria:

  • Blood pressure over 140/90
  • Type I or Type II diabetes
  • Renal, hepatic or cardiac disease
  • Current infectious disease
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
61 participants (actual)

Study arms

  • Active comparator
    150mg olive extract

    Dietary Supplement: Olive Extract

  • Active comparator
    50mg olive extract

    Dietary Supplement: Olive Extract

  • Placebo comparator
    Placebo control

    Dietary Supplement: Placebo

Interventions

  • Dietary supplementOlive Extract

    Capsule form ingested 1x/day for 6 weeks

  • Dietary supplementPlacebo

    Placebo

06

What researchers measure

Primary outcomes

  1. Improved Antioxidant Status

    Time frame: 6 weeks

Secondary outcomes

  1. Reduced Inflammation

    Time frame: 6 weeks

07

Study locations

1 site
  • The University of Texas at Austin
    Austin, Texas 78712, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 27, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01113827
Lead sponsor
University of Texas at Austin
Collaborators
DSM Nutritional Products, Inc.
Responsible party
Sponsor
First posted
Apr 30, 2010
Start date
Feb 2010
Primary completion
Jul 2011
Completion
Feb 2012
Last update
Mar 27, 2012

Study contacts

John Ivy, Ph.D.
principal investigator · The University of Texas at Austin

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion